MedTrace Logo

Strengthening Community Mental Health

NCT06093737 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-10-23

No results posted yet for this study

Summary

The goal of this clinical trial is to examine the impact of the Communities Organizing for Power through Empathy (COPE) intervention in adults in communities having recently experienced or at risk of experiencing disaster. The main questions it aims to answer are:

* How does the COPE intervention affect individual mental health?
* How does the COPE intervention affect protective factors like coping and social support?
* How does the COPE intervention affect community resilience?
* How does delivery of the COPE intervention in partnership with a broad-based organization affect participant recruitment and retention, as well as outcomes?

Participants will participate in the three session COPE intervention. Researchers will compare individuals who participate in the COPE intervention to individuals who participate in house meetings to see if the COPE intervention improves mental health, coping, social support and community resilience. Researchers will also examine factors that affect implementation and intervention delivery.

Conditions

Interventions

BEHAVIORAL

COPE: Communities Organizing for Power through Empathy

A three session brief group psychoeducational intervention. Session 1 is 4 hours, Session 2 and 3 are 1.5 hours. It is delivered in groups of 8-15 people with sessions spaced 1 month apart.

Sponsors & Collaborators

  • National Academies of Sciences, Engineering and Medicine

    collaborator UNKNOWN

  • University of Illinois at Urbana-Champaign

    collaborator OTHER

  • Louisiana State University and A&M College

    lead OTHER

Principal Investigators

  • Jennifer L Scott, PhD, LCSW · Louisiana State University Health Sciences Center in New Orleans

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-25
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06093737 on ClinicalTrials.gov